Pricing Log in Create free account
Friday 6 November 2026 Export TEVA’s income statement to Excel — free account

Teva Pharmaceutical Industries Ltd.

TEVA Healthcare Drug Manufacturers Specialty & Generic

Teva Pharmaceutical Industries Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $17.3 billion, up 4.32% from fiscal 2024.

Revenue
−1.90%
EPS
−47.2%
Free cash flow
−30.3%
Total debt
−0.43%

Quarter to September 2026, against a year earlier

41.73 0.12 −0.29%
Market cap
$48.7B
P/E
92.6×
Fwd P/E
30.7×
Dividend yield
—
F-score
8/9
Altman Z
0.79
Beneish M
−2.35
Dividend safety
52/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Teva Pharmaceutical Industries Ltd. (TEVA) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Teva Pharmaceutical Industries Ltd. (TEVA) trades at a P/B ratio of 6.1×. Over the past ten years it has ranged from 0.3× (October 2019) to 6.1× (October 2026); the current reading is higher than 100% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 1.8× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 4.5× (2.54%)
FY2024 4.6× 215.30%
FY2023 1.5× 19.44%
FY2022 1.2× 45.12%
FY2021 0.8× (11.24%)
FY2020 1.0× 34.57%
FY2019 0.7× (28.79%)
FY2018 1.0× (1.14%)
FY2017 1.0× (11.62%)
FY2016 1.1× (45.85%)

Quarterly newest first

Period P/B ratio Change
Sep 2026 5.8× 13.66%
Jun 2026 5.1× 20.30%
Mar 2026 4.2× (6.33%)
Dec 2025 4.5× 41.37%
43 more quarters

Against its own ten years

Low 0.3× High 6.1×
Ten-year median 1.3×
Current reading's percentile 100

P/B ratio against peers

Company P/B ratio
TAK Takeda Pharmaceutical Co. compare 1.4×
VTRS Viatris Inc. compare 1.6×
ELAN Elanco Animal Health Incorporated compare 1.8×
HLN Haleon PLC Sponsored ADR compare 1.9×
RDY Dr. Reddy's Laboratories Ltd compare 3.0×
UTHR United Therapeutics Corporation compare 3.8×
NBIX Neurocrine Biosciences, Inc. compare 4.2×
TEVA Teva Pharmaceutical Industries Ltd. 6.1×
ZTS Zoetis Inc. compare 10.8×
Drug Manufacturers Specialty & Generic industry median 1.8×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on TEVA